Increased genetic testing has however revealed that germline TP53 variants are associated with a broader range of phenotypes, from classical LFS to hereditary breast cancer (HBC), and the outcome may be dependent on both variant characteristics and modifier gene variants elsewhere in the genome [40]. This evidence concerns the gene TP53 and Hereditary breast cancer.